MARKET WIRE NEWS

(DMAC) Investment Report

Source: Stock Traders Daily

2025-07-22 14:06:00 ET

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in Diamedica Therapeutics Inc. (NASDAQ: DMAC) with integrated risk controls.

Warning:

The trading plans were valid at the time this was published, but the support and resistance levels for DMAC change as time passes, and this should be updated in real time.  Access those real time updates for this and 1000 other stocks here. Unlimited Real Time Reports

Protection from Market Crashes: Subscribers also get our Tail Risk hedge, Evitar Corte

Instructions:

Use the basic rules of Technical Analysis.  Here are some examples: if DMAC is testing support the signal is to buy and target resistance.  On the other hand, if resistance is tested, that is a sign to short, and target support.  No matter which side the trade is, long or short, the trigger point is both a place to enter and as a risk control.

Swing Trades, Day Trades, and Longer term Trading Plans:

This data can be used to define Day Trading, Swing Trading, and Long Term Investing plans for DMAC too.  All of these are offered here: Access our Real Time Trading Plans




DiaMedica Therapeutics Inc.

NASDAQ: DMAC

DMAC Trading

-5.35% G/L:

$7.07 Last:

92,570 Volume:

$7.32 Open:

mwn-app Ad 300

DMAC Latest News

DMAC Stock Data

$439,533,585
29,684,140
16.95%
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Minneapolis

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App